Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

Inner-health ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading... Loading... Loading... Loading...

1000.0 Bankruptcy Risk  2017 2017/9 2018 2018/9 2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023e N/A 2024e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 5.4% 5.4%   Bankruptcy risk   19.2% 14.1% 15.7% 17.9% 12.5% 16.1% 18.0% 18.0%   Credit score (0-100)   8 17 13 8 17 11 7 8   Credit rating   B BB BB B BB BB B B   Credit limit (kDKK)   -0.0 -0.0 -0.0 -0.0 -0.0 -0.0 -0.0 -0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2017 2017/9 2018 2018/9 2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023e N/A 2024e N/A Net sales   240 0 0 0 0 0 0 0   Gross profit   12.0 54.2 29.6 -120 92.5 0.0 0.0 0.0   EBITDA   -70.8 40.4 -36.5 -166 92.5 0.0 0.0 0.0   EBIT   -82.1 29.1 -51.5 -192 71.6 0.0 0.0 0.0   Pre-tax profit (PTP)   -86.7 29.0 -51.7 -191.6 71.3 0.0 0.0 0.0   Net earnings   -96.0 29.0 -51.7 -191.6 71.3 0.0 0.0 0.0   Pre-tax profit without non-rec. items   -86.7 29.0 -51.7 -192 71.3 0.0 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2017 2017/9 2018 2018/9 2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023e N/A 2024e N/A Tangible assets total   33.9 22.6 82.6 56.2 88.2 0.0 0.0 0.0   Shareholders equity total   -107 -78.4 -130 -322 -250 -250 -300 -300   Interest-bearing liabilities   30.6 1.9 92.2 286 246 231 300 300   Balance sheet total (assets)   95.8 98.2 147 142 101 1.0 0.0 0.0   Net Debt   15.0 -6.7 90.6 277 233 230 300 300     See the entire balance sheet 1000.0 Volume  2017 2017/9 2018 2018/9 2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023e N/A 2024e N/A Net sales   240 0 0 0 0 0 0 0   Net sales growth   0.0% -100.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   12.0 54.2 29.6 -120 92.5 0.0 0.0 0.0   Gross profit growth   -93.1% 350.2% -45.4% 0.0% 0.0% -100.0% 0.0% 0.0%   Employees   1 1 1 1 0 0 0 0   Employee growth %   0.0% 0.0% 0.0% 0.0% -100.0% 0.0% 0.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   96 98 147 142 101 1 0 0   Balance sheet change%   -33.9% 2.5% 49.7% -3.7% -28.4% -99.0% -100.0% 0.0%   Added value   -70.8 40.4 -36.5 -165.8 98.0 0.0 0.0 0.0   Added value %   -29.5% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   -23 -23 45 -53 11 -88 0 0   Net sales trend   0.0 -1.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   -2.0 1.0 -1.0 -2.0 1.0 0.0 0.0 0.0   1000.0 Profitability  2017 2017/9 2018 2018/9 2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023e N/A 2024e N/A EBITDA %   -29.5% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   -34.2% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   -682.1% 53.6% -173.9% 159.6% 77.3% 0.0% 0.0% 0.0%   Net Earnings %   -39.9% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   -35.2% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   -36.1% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   -45.7% 15.3% -22.7% -51.7% 17.6% 0.0% 0.0% 0.0%   ROI %   -537.0% 179.0% -109.4% -101.3% 26.9% 0.0% 0.0% 0.0%   ROE %   -79.7% 29.8% -42.2% -132.7% 58.7% 0.0% 0.0% 0.0%   1000.0 Solidity  2017 2017/9 2018 2018/9 2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023e N/A 2024e N/A Equity ratio %   -52.8% -44.4% -46.9% -69.4% -71.2% -99.6% -100.0% -100.0%   Relative indebtedness %   84.5% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   78.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   -21.2% -16.6% -248.4% -166.8% 251.3% 0.0% 0.0% 0.0%   Gearing %   -28.5% -2.4% -70.9% -88.9% -98.2% -92.4% -100.0% -100.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   30.0% 0.7% 0.5% 0.1% 0.1% 0.0% 0.0% 0.0%   1000.0 Liquidity  2017 2017/9 2018 2018/9 2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023e N/A 2024e N/A Quick Ratio   0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current Ratio   0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.0   Cash and cash equivalent   15.6 8.6 1.6 9.5 13.2 1.0 0.0 0.0   1000.0 Capital use efficiency  2017 2017/9 2018 2018/9 2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023e N/A 2024e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   96.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   6.5% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   -187.6 -147.3 -259.0 -447.9 -338.6 -250.4 -150.2 -150.2   Net working capital %   -78.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2017 2017/9 2018 2018/9 2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023e N/A 2024e N/A Net sales / employee   240 0 0 0 0 0 0 0   Added value / employee   -71 40 -36 -166 0 0 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   -71 40 -36 -166 0 0 0 0   EBIT / employee   -82 29 -51 -192 0 0 0 0   Net earnings / employee   -96 29 -52 -192 0 0 0 0